Early-Stage TNBC: What are the Roles of PARPIs?
Making a Difference in Survival: Integrating New Therapies for Triple-Negative Breast Cancer
Click the "View Activity" button to view this activity.View Activity
CME/CE is no longer available for this activity
-Discuss new targeted treatment approaches in the setting of triple-negative breast cancer
-Assess the current evidence and treatment recommendations with the PARPIs for TNBC
-Implement strategies to facilitate the use of novel therapies for TNBC in community-based settings
Professor and Vice-Chair
UC San Diego Health
San Diego, CA
The University of Chicago Pritzker School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The University of Chicago Pritzker School of Medicine designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.Other Healthcare Professional Credit
Nurses and other healthcare professionals will receive a Certificate of Participation. For information on the applicability and acceptance of Certificates of Participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME, please consult your professional licensing board.